Research Comparison

5-Amino-1MQ vs Lipo-C (MIC + B Vitamins)

5-Amino-1MQ and Lipo-C (MIC + B Vitamins) side by side, each from its own compound record: what it is, how it acts, and the values the record holds.

5-Amino-1MQ

5-Amino-1MQ is a small quinolinium molecule, not a peptide, designed to inhibit the enzyme nicotinamide N-methyltransferase (NNMT). It came out of medicinal-chemistry work on a series of methylquinolinium analogues screened against that enzyme, which methylates nicotinamide and is expressed at high levels in liver and fat tissue. Interest in NNMT grew once it was linked to the balance of NAD+ and of methyl donors inside cells. Published work on 5-Amino-1MQ is preclinical: enzyme assays, cultured fat cells and diet-induced obese mouse models. Human data are very limited, and its selectivity and behaviour in the whole organism are not well characterised.

Lipo-C (MIC + B Vitamins)

Lipo-C is a blend of methionine, inositol and choline (MIC) with B vitamins, including vitamin B12; none of its components is a peptide. Methionine is an essential sulphur-containing amino acid, inositol a cyclic sugar alcohol, choline a small quaternary ammonium nutrient, and vitamin B12 (cobalamin) a corrinoid cofactor. Each ingredient has a long literature of its own in nutrition and biochemistry, drawn from cell, animal and human studies. The blend has none: no published study appears to have examined these components supplied together, so nothing reported for any single ingredient can be carried over to the mixture.

How 5-Amino-1MQ acts

NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine. 5-Amino-1MQ is thought to occupy the enzyme's nicotinamide site and compete with the natural substrate. Because the reaction consumes both SAM and nicotinamide, a precursor recycled into NAD+ through the salvage pathway, inhibitors of this kind have been used in cultured adipocytes and rodent studies to examine how NNMT activity relates to intracellular NAD+ and SAM levels and to lipid handling in fat cells. How selective the compound is across other methyltransferases, and how it is distributed and cleared in animals, has been only partly described.

How Lipo-C (MIC + B Vitamins) acts

The ingredients meet in methyl-group (one-carbon) metabolism. Methionine is converted to S-adenosylmethionine, the main methyl donor for cellular methylation reactions; once it has given up its methyl group, the product is broken down to homocysteine. Homocysteine can be turned back into methionine by two routes: methionine synthase, which depends on vitamin B12 as methylcobalamin, and a second enzyme that uses betaine, made in cells by oxidising choline. Choline is also the precursor of phosphatidylcholine, a major phospholipid of cell membranes and lipoproteins, and of the neurotransmitter acetylcholine. Inositol is built into phosphatidylinositol and the inositol phosphates used in intracellular signalling. These are features of normal biochemistry, not findings for the blend.

The records side by side

  • Type: 5-Amino-1MQ, Small molecule (quinolinium cation); Lipo-C (MIC + B Vitamins), Multi-component blend
  • Molecular weight: 5-Amino-1MQ, 159.21 g/mol; Lipo-C (MIC + B Vitamins), not recorded
  • Molecular formula: 5-Amino-1MQ, C10H11N2+; Lipo-C (MIC + B Vitamins), not recorded

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.